Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Immutep - Notice of Annual General Meeting/Proxy Form (ASX:IMM)

Immutep Limited (the Company) is convening its 2020 Annual General Meeting (AGM) at 10:30 am (AEDT) on Tuesday, 27th October 2020. Due to the COVID-19 pandemic and related issues, the AGM will be...read more

Immutep - Appendix 4G & Corporate Governance Statement (ASX:IMM)

To view the appendix, download the attached PDF.

Immutep - Annual Report to shareholders (ASX:IMM)

To view the report, download the attached PDF.

Elixinol Global - Change of Share Registry (ASX:EXL)

Elixinol Global Limited (Elixinol Global) (ASX:EXL; OTC:ELLXF) advises that as of Monday, 28 September 2020, Elixinol Global has changed its provider for shareholder registry services from Computers...read more

Cyclopharm Investor Presentation (ASX:CYC)

To view the presentation, download the attached PDF.

Elixinol Global Trading Update (ASX:EXL)

Elixinol Global Limited (Elixinol or the Company) (ASX:EXL; OTC:ELLXF) is pleased to announce a trading update for the September quarter (Q3 FY2020). Despite the COVID-19 situation impacting Elix...read more

Elixinol Global Announces Appendix 3Y - Paul Benhaim (ASX:EXL)

In accordance with ASX Listing Rule 3.19A.2, Elixinol Global Limited (Elixinol or the Company) provides an Appendix 3Y for Mr Paul Benhaim. The Company refers to the market announcement on 17 Jun...read more

Elixinol Global - Appendix 3Y - Paul Benhaim (ASX:EXL)

Immutep - Improving results from stage 1 of TACTI-002 ph II trial (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) announces new interim data from its ongoing Phase II TACTI-002 study. The data was presented in two poster presentations at the ESMO Virtual Congress 2020 on...read more

Immutep reports improving results from INSIGHT-004 trial (ASX:IMM)

Immutep Limited (ASX: IMM; NASDAQ: IMMP) is pleased to report further interim data from its ongoing INSIGHT-004 Phase I clinical trial. The data were presented at the ESMO Virtual Congress 2020 on 1...read more

MMJ Group Holdings - Annual Report to shareholders (ASX:MMJ)

To view the report, download the attached PDF.

MMJ Group Holdings - Appendix 4G and Corporate Governance Statement (ASX:MMJ)

MMJ Group Holdings Limited (ASX:MMJ/OTC Code MMJJF) ("MMJ"), an Australian-listed company that specialises in managing a portfolio of investments along the cannabis value-chain in Australi...read more

Cyclopharm Announces Technegas USA Trial Successfully Meets Primary Endpoint (ASX:CYC)

Radiopharmaceutical company, Cyclopharm Limited (ASX: CYC) is pleased to confirm that an independent Data Monitoring Efficacy Committee (DEMC), requested by the USFDA as part of its assessment...read more

Elixinol Global - H1 FY2020 Interim Report (ASX:EXL)

To view the report, download the attached PDF.

Elixinol Global - H1 FY2020 Interim Report Announcement (ASX:EXL)

Following the announcement made on 31 August 2020 “H1 FY2020 Results – Strategic Reset and Improving Outlook”, Elixinol releases its Interim Report which has now been reviewed by i...read more

Viewing: 1 - 15 of 200 Previous | Next